Detalhe da pesquisa
1.
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Blood;
140(7): 756-768, 2022 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35443031
2.
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.
Blood;
137(20): 2827-2837, 2021 05 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33881523
3.
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
BMC Bioinformatics;
23(1): 448, 2022 Oct 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36307762
4.
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.
BMC Bioinformatics;
23(1): 533, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36494771
5.
Targeting a lineage-specific PI3KÉ£-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.
Nat Cancer;
2024 May 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38816660
6.
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
Blood Cancer Discov;
4(2): 134-149, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36630200
7.
Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.
Cell Stem Cell;
30(2): 153-170.e9, 2023 02 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36736290
8.
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.
Leukemia;
36(3): 656-663, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34615986
9.
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Blood Cancer J;
12(6): 95, 2022 06 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35750691
10.
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Clin Cancer Res;
28(23): 5211-5220, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36201165
11.
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Leukemia;
36(6): 1585-1595, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35474100
12.
Clonal Architecture and Evolutionary Dynamics in Acute Myeloid Leukemias.
Cancers (Basel);
13(19)2021 Sep 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34638371
13.
Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers.
Hemasphere;
5(9): e632, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34423258
14.
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy.
Leukemia;
35(3): 712-723, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32581253
15.
High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients.
Mult Scler Relat Disord;
46: 102470, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32889375
16.
Clinical update on hypomethylating agents.
Int J Hematol;
110(2): 161-169, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31020568
17.
Germline CHEK2 mutations in patients with myeloid neoplasms.
Leukemia;
38(4): 908-911, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38378842
18.
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.
Leukemia;
38(4): 918-922, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38368440
19.
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia.
Leukemia;
33(10): 2466-2480, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30894665
20.
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.
EBioMedicine;
31: 174-181, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29728305